Lung Cancer Trials Ask AI to find trials
CompletedNot applicableNCT01648166
Official study title

Study of Lung Cancer in Appalachian Kentucky: The Role of Environmental Carcinogens

Study summary

This is a research study about the relationship between lung cancer and environmental risk factors. The purpose of this study is to try to understand the effects of trace elements such as arsenic and chromium, as well as radon on the development of lung cancer. To do this, the investigators will collect information and environmental and biologic specimens from people who live in Appalachian Kentucky who a) have lung cancer or b) don't have lung cancer and will serve as control subjects. The investigators will create a specimen repository of from these people and their residences to compare differences in many risks factors for cancer. By doing this study, the investigators hope to learn why there are more lung cancers in Kentucky's fifth Congressional District than anywhere else in the nation.

Ask AI to explain this study
Start here

Key things to know

Main goalNot specified

This describes the study’s primary purpose.

What is being studiedEnvironmental sampling

The study team can explain what participation involves.

Who it may be forLung Cancer

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Nov 7, 2019 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Observational

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?Susanne Arnold

Study sponsor

01
Study overview

What this study is about

Purpose
Not specified
Study type
Observational
Phase
Not applicable
Sponsor
Susanne Arnold
Interventions being studied
Other: Environmental sampling
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • The following eligibility criteria are required for study entry and participation. Inclusion (Lung cancer cases):
  • Living persons with histologically or cytologically confirmed primary carcinoma of the lung (International Classification of Diseases-9, 162.2-162.9) between October 17, 2011 and October 16, 2013
  • Age greater than 17
  • Must be residents of the 5th Congressional District
  • No prior history of any cancer (other than stage I and II non-melanomatous skin cancer)
  • Must have a working phone
  • Ability to participate in an in-person interview
  • English speaking will be eligible for the study (no proxy respondents will be used) Inclusion (Control cases):
  • Age greater than 17
  • No prior history of any cancer (other than stage I and II non-melanomatous skin cancer)
  • Must be residents of the 5th Congressional District at the time they are matched to the case.
  • Must have a working phone
  • Ability to participate in an in-person interview
  • English speaking will be eligible for the study (no proxy respondents will be used) Exclusion:
  • History of any cancers other than those listed above
  • Non-residents of the 5th congressional district of Kentucky
  • Age 17 years or less

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • University of KentuckyLexington, Kentucky

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Nov 7, 2019. Always confirm current availability with the study team.

View original record ↗